Galderma Launches Alastin® in China, Supporting the Skin’s Natural Regenerative Abilities in a Rapidly Expanding Market

Galderma marks the 10th anniversary of its premium medical skincare brand Alastin with the launch of four core products in China, each formulated to support the skin’s natural regenerative abilities to help with skin recovery before and after aesthetic procedures1,2 This is the first launch to feature Alastin’s new packaging and builds on its strong … [Read more…]

Align Technology Hosts the 2025 Invisalign® GP Summit, Its Premier Education Event for Dental Practices to Explore the Latest Invisalign® System, iTero™ Scanner, and Align™ Digital Platform Innovations

Clinical Workshops and Innovation Hub Showcased Solutions to Enhance Digital Orthodontics, Comprehensive Dentistry, and Ortho-Restorative Workflows Celebrations honored doctors and practice teams who have helped transform 20M+ Smiles with Invisalign Treatment Align Women’s Smile Collective initiative launched to celebrate, support, and spotlight women shaping the future of dentistry LAS VEGAS & SAN JOSE, Calif. & … [Read more…]

Henry Schein Announces $750 Million Share Repurchase Plan

MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care products and services to office-based dental and medical practitioners, announced today that its Board of Directors has authorized the repurchase of up to $750 million of shares of the Company’s common stock. This program is in addition to the $500 million … [Read more…]

Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock

CAMBRIDGE, Mass.–(BUSINESS WIRE)–$AMLX—Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares of common stock are being offered by Amylyx. In addition, Amylyx intends to grant the underwriters a 30-day option to purchase additional shares of … [Read more…]

Pandemic Agreement Annex Negotiations Must Deliver Equity, Transparency, and Accountability, says AHF

MIAMI–(BUSINESS WIRE)–#COVID19–As governments gather in Geneva for the second Intergovernmental Working Group (IGWG) session on the Pathogen Access and Benefit Sharing (PABS) Annex next week, the stakes are high. These negotiations will determine whether Member States have the resolve to take meaningful steps to correct the unacceptable inequities laid bare by the COVID-19 pandemic—by placing … [Read more…]

LightSpun Secures $13M Series A to Redefine Dental Insurance Administration with AI

Lightspun’s AI-powered automation enables 90%+ of claims to be auto-adjudicated, reduces provider onboarding from 45–60 days to under a week, and halves administrative costs BOSTON–(BUSINESS WIRE)–LightSpun (formerly 32Health), an AI-powered dental insurance administration platform, has raised $13 million in Series A funding led by Brewer Lane with Virtue, Cambrian, and Industry Ventures participating. Rohan Malhotra … [Read more…]

Newleos Therapeutics Announces Poster Presentation to be Featured at the 2025 World Congress of Biological Psychiatry

– Results of preclinical studies on selective GABAA γ1 positive allosteric modulators (PAMs) in anxiety models support further clinical development of NTX-1955 – BOSTON–(BUSINESS WIRE)–#AnxietyDisorders—Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric disorders, today announced the presentation of a poster related to the company’s first-in-class GABAA γ1 positive allosteric modulator (PAM), … [Read more…]

‘RevoAb™’, A New Service for Antibody Developability Engineering

SENDAI, Japan–(BUSINESS WIRE)–RevolKa Ltd. (RevolKa), a venture-backed biotech company providing a cutting-edge AI-driven protein engineering technology platform, called aiProtein® is pleased to announce the launch of a new contract research service, ‘RevoAb™’. This service engineers antibodies to improve physicochemical properties while protecting antigen binding affinity. About RevoAb™ Since December 2023, RevolKa has offered contract research … [Read more…]

MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor

MISSISSAUGA, Ontario–(BUSINESS WIRE)–MedX Health Corp. (TSXV: MDX), “MedX” or the “Company”), a global leader in teledermatology and non-invasive skin analysis, today announced the appointment of Dr. Paul J. Matts, internationally recognized skin scientist, biochemist and educator, as Strategic Advisor to the Company. Dr. Matts joined Procter & Gamble (P&G) in 1988 as a PhD biochemist … [Read more…]

New Arizona’s Bioscience Roadmap Details How the State Becomes a Nationally Recognized Bioscience Hub

The Flinn Foundation has commissioned a new Arizona’s Bioscience Roadmap to guide discovery, innovation, and economic growth through 2030 The strategic plan was first launched more than two decades ago and includes goals for accelerating commercialization, empowering startups, and developing and retaining workers Developed by SRI International of Menlo Park, Calif., the plan will be … [Read more…]